Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1992-7-29
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1060-0280
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:pagination |
868
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:1611176-Cooperative Behavior,
pubmed-meshheading:1611176-Drug Compounding,
pubmed-meshheading:1611176-Drug Industry,
pubmed-meshheading:1611176-Drug Prescriptions,
pubmed-meshheading:1611176-Humans,
pubmed-meshheading:1611176-Pharmacy,
pubmed-meshheading:1611176-United States,
pubmed-meshheading:1611176-United States Food and Drug Administration
|
pubmed:year |
1992
|
pubmed:articleTitle |
Compliance policy guide addresses prescription drug compounding.
|
pubmed:publicationType |
Guideline,
Comparative Study,
News
|